Cite
Value of intravenous alteplase before thrombectomy among patients with tandem lesions and emergent carotid artery stenting: A subgroup analysis of the SWIFT DIRECT trial.
MLA
Mujanovic, Adnan, et al. “Value of Intravenous Alteplase before Thrombectomy among Patients with Tandem Lesions and Emergent Carotid Artery Stenting: A Subgroup Analysis of the SWIFT DIRECT Trial.” European Journal of Neurology, vol. 31, no. 6, June 2024, pp. 1–10. EBSCOhost, https://doi.org/10.1111/ene.16256.
APA
Mujanovic, A., Dobrocky, T., Pfeilschifter, W., Remonda, L., Caroff, J., Behme, D., Seiffge, D. J., Cereda, C. W., Kägi, G., Leyon, J., Piechowiak, E. I., Costalat, V., Wagner, J., Chabert, E., Meinel, T. R., Jansen, O., Alonso, A., Loehr, C., Liebeskind, D. S., & Gralla, J. (2024). Value of intravenous alteplase before thrombectomy among patients with tandem lesions and emergent carotid artery stenting: A subgroup analysis of the SWIFT DIRECT trial. European Journal of Neurology, 31(6), 1–10. https://doi.org/10.1111/ene.16256
Chicago
Mujanovic, Adnan, Tomas Dobrocky, Waltraud Pfeilschifter, Luca Remonda, Jildaz Caroff, Daniel Behme, David J. Seiffge, et al. 2024. “Value of Intravenous Alteplase before Thrombectomy among Patients with Tandem Lesions and Emergent Carotid Artery Stenting: A Subgroup Analysis of the SWIFT DIRECT Trial.” European Journal of Neurology 31 (6): 1–10. doi:10.1111/ene.16256.